Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Fort Lee, New Jersey
- Most recent report
- 10-Q, filed Aug 4, 2026
- Incorporated
- Delaware
- Filings on record
- 270 filings
- On EDGAR
- CIK 1875558
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 20
News 8 of 36
Prospectuses and Registrations 8 of 23
- 424B5 Prospectus supplement for an offering Jun 30, 2026
- 424B5 Prospectus supplement for an offering Jun 29, 2026
- S-3 Shelf registration statement Feb 13, 2026
- 424B5 Prospectus supplement for an offering May 9, 2025
- 424B5 Prospectus supplement for an offering Feb 6, 2025
- 424B5 Prospectus supplement for an offering Feb 4, 2025
- S-8 Registration statement for an employee plan Jan 3, 2025
- S-8 Registration statement for an employee plan Aug 9, 2023
Proxies 7
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 153
- SCHEDULE 13G Large holder reported a passive stake Aug 6, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
Other 8 of 31
- EFFECT Notice that a registration became effective Feb 20, 2026
- CORRESP Reply to SEC staff Feb 18, 2026
- UPLOAD Comment letter from SEC staff Feb 18, 2026
- EFFECT Notice that a registration became effective Mar 29, 2023
- CORRESP Reply to SEC staff Mar 27, 2023
- UPLOAD Comment letter from SEC staff Mar 21, 2023
- EFFECT Notice that a registration became effective Aug 24, 2022
- CORRESP Reply to SEC staff Aug 23, 2022
Everything here comes from Nuvectis Pharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.